HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Na-Ling Kang Selected Research

guanidinopropylsuccinic acid (GPSA)

6/2022Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Na-Ling Kang Research Topics

Disease

3Infections
06/2022 - 01/2020
3Chronic Hepatitis B
06/2022 - 01/2020
3Fibrosis (Cirrhosis)
06/2022 - 07/2020
3Liver Cirrhosis (Hepatic Cirrhosis)
06/2022 - 07/2020
1Inflammation (Inflammations)
02/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021

Drug/Important Bio-Agent (IBA)

3Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2022 - 07/2020
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2022 - 07/2020
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
06/2022 - 07/2020
2Alanine Transaminase (SGPT)IBA
02/2021 - 07/2020
2Antiviral Agents (Antivirals)IBA
01/2021 - 07/2020
2Ceruloplasmin (Ferroxidase)IBA
07/2020 - 01/2020
1guanidinopropylsuccinic acid (GPSA)IBA
06/2022
1AlbuminsIBA
06/2022
1Biological ProductsIBA
02/2021
1Hepatitis B e AntigensIBA
01/2021
1Indicators and Reagents (Reagents)IBA
07/2020

Therapy/Procedure

2Therapeutics
01/2021 - 07/2020